{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:55:31Z","timestamp":1790416531257,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.rbmo.2019.02.004","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T02:51:41Z","timestamp":1551235901000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Pregnancy and neonatal complications in women with polycystic ovary syndrome in relation to second-trimester anti-M\u00fcllerian hormone levels"],"prefix":"10.1016","volume":"39","author":[{"given":"Ragnheidur","family":"Valdimarsdottir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiddis","family":"Valgeirsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Karin","family":"Wikstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora Kunovac","family":"Kallak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Elenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ove","family":"Axelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumari","family":"Ubhayasekhera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terhi T","family":"Piltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Pigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Giacobini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger Sundstr\u00f6m","family":"Poromaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2019.02.004_bib0001","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humupd\/dmi013","article-title":"Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?","volume":"11","author":"Abbott","year":"2005","journal-title":"Human reproduction update"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0002","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.2174\/1381612822666160715133437","article-title":"Translational Insight Into Polycystic Ovary Syndrome (PCOS) From Female Monkeys with PCOS-like","volume":"22","author":"Abbott","year":"2016","journal-title":"Traits Current pharmaceutical design"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0003","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3109\/14767058.2014.937418","article-title":"Maternal serum anti-Mullerian hormone at 11-13 weeks' gestation in the prediction of preeclampsia","volume":"28","author":"Birdir","year":"2015","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"key":"10.1016\/j.rbmo.2019.02.004_bib0004","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0005","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/ajo.12647","article-title":"Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome","volume":"57","author":"Bradbury","year":"2017","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"10.1016\/j.rbmo.2019.02.004_bib0006","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/humupd\/dmu020","article-title":"Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications","volume":"20","author":"Broer","year":"2014","journal-title":"Human reproduction update"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0007","article-title":"Androgen production in women","volume":"77 Suppl 4","author":"Burger","year":"2002","journal-title":"Fertility and sterility"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.03.032","article-title":"Age-specific serum antimullerian hormone levels in women with and without polycystic ovary syndrome","volume":"102","author":"Cui","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.02.004_bib0009","doi-asserted-by":"crossref","first-page":"8066","DOI":"10.1038\/s41598-017-08559-w","article-title":"The effect of androgen excess on maternal metabolism, placental function and fetal growth in obese dams","volume":"7","author":"Fornes","year":"2017","journal-title":"Scientific reports"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0010","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s12020-014-0515-4","article-title":"Anti-mullerian hormone concentration during the third trimester of pregnancy and puerperium: a longitudinal case-control study in normal and diabetic pregnancy","volume":"50","author":"Gerli","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0011","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/AOG.0000000000000344","article-title":"Targeted thyroid testing during pregnancy in clinical practice","volume":"124","author":"Granfors","year":"2014","journal-title":"Obstetrics and gynecology"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0012","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/humrep\/den482","article-title":"Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve","volume":"24","author":"Hudecova","year":"2009","journal-title":"Human reproduction (Oxford, England)"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0013","doi-asserted-by":"crossref","DOI":"10.1111\/cen.13755","article-title":"Simplified 4-item criteria for polycystic ovary syndrome: A bridge too far?","author":"Indran","year":"2018","journal-title":"Clinical endocrinology"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0014","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/EJE-17-0207","article-title":"Maternal and female fetal testosterone levels are associated with maternal age and gestational weight gain","volume":"177","author":"Kallak","year":"2017","journal-title":"European journal of endocrinology"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1477-7827-11-60","article-title":"Anti-Mullerian-hormone levels during pregnancy and postpartum","volume":"11","author":"Koninger","year":"2013","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.rbmo.2019.02.004_bib0016","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1477-7827-11-60","article-title":"Anti-Mullerian-hormone levels during pregnancy and postpartum","volume":"11","author":"Koninger","year":"2013","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.rbmo.2019.02.004_bib0017","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejogrb.2012.10.015","article-title":"Placental steroidogenesis in pregnant women with polycystic ovary syndrome","volume":"166","author":"Maliqueo","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.rbmo.2019.02.004_bib0018","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1651-2227.1996.tb14164.x","article-title":"Intrauterine growth curves based on ultrasonically estimated foetal weights","volume":"85","author":"Marsal","year":"1996","journal-title":"Acta paediatrica (Oslo, Norway: 1992)"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0019","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1210\/en.2012-1954","article-title":"Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome","volume":"154","author":"Moore","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0020","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1073\/pnas.1415038112","article-title":"Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome","volume":"112","author":"Moore","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0021","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.fertnstert.2009.07.1676","article-title":"Longitudinal assessment of antimullerian hormone during pregnancy-relationship with maternal adiposity, insulin, and adiponectin","volume":"93","author":"Nelson","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0022","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.fertnstert.2009.07.1676","article-title":"Longitudinal assessment of antimullerian hormone during pregnancy-relationship with maternal adiposity, insulin, and adiponectin","volume":"93","author":"Nelson","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0023","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2012.10.005","article-title":"Sheep models of polycystic ovary syndrome phenotype","volume":"373","author":"Padmanabhan","year":"2013","journal-title":"Molecular and cellular endocrinology"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0024","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/humupd\/dmv029","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"21","author":"Palomba","year":"2015","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0025","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","article-title":"Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome","volume":"91","author":"Pigny","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rbmo.2019.02.004_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2018.11.028","article-title":"Circulating antimullerian hormone and steroid hormone levels remain high in pregnant women with polycystic ovary syndrome at term","author":"Piltonen","year":"2019","journal-title":"Fertility and sterility"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0027","doi-asserted-by":"crossref","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). 2004. Human reproduction (Oxford, England) 19,41-47.","DOI":"10.1093\/humrep\/deh098"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0028","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/ajo.12183","article-title":"Evaluation of anti-Mullerian hormone in the first trimester as a predictor for hypertensive disorders of pregnancy and other adverse pregnancy outcomes","volume":"54","author":"Shand","year":"2014","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"10.1016\/j.rbmo.2019.02.004_bib0029","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/ajh.2011.175","article-title":"Maternal body mass index, height, and risks of preeclampsia","volume":"25","author":"Sohlberg","year":"2012","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.rbmo.2019.02.004_bib0030","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00421.2012","article-title":"Maternal androgen excess reduces placental and fetal weights, increases placental steroidogenesis, and leads to long-term health effects in their female offspring","volume":"303","author":"Sun","year":"2012","journal-title":"American journal of physiology Endocrinology and metabolism"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0031","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-018-0035-5","article-title":"Elevated prenatal anti-Mullerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood","author":"Tata","year":"2018","journal-title":"Nature medicine"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0032","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/S0021-9258(20)79736-X","article-title":"The involvement of human placental microsomal cytochrome P-450 in aromatization","volume":"249","author":"Thompson","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.rbmo.2019.02.004_bib0033","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3109\/14767058.2014.955007","article-title":"May maternal anti-mullerian hormone levels predict adverse maternal and perinatal outcomes in preeclampsia?","volume":"28","author":"Tokmak","year":"2015","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"key":"10.1016\/j.rbmo.2019.02.004_bib0034","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.fertnstert.2011.11.021","article-title":"Androgens and antimullerian hormone in mothers with polycystic ovary syndrome and their newborns","volume":"97","author":"Vanky","year":"2012","journal-title":"Fertility and sterility"},{"key":"10.1016\/j.rbmo.2019.02.004_bib0035","doi-asserted-by":"crossref","first-page":"E448","DOI":"10.1210\/jc.2010-0853","article-title":"Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study","volume":"95","author":"Vanky","year":"2010","journal-title":"The Journal of clinical endocrinology and metabolism"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648319301014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648319301014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T17:53:32Z","timestamp":1663005212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648319301014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1472648319301014"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2019.02.004","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy and neonatal complications in women with polycystic ovary syndrome in relation to second-trimester anti-M\u00fcllerian hormone levels","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2019.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}